Breaking News Instant updates and real-time market news.

TEAM

Atlassian

$111.23

-2.02 (-1.78%)

08:27
04/18/19
04/18
08:27
04/18/19
08:27

Atlassian price target raised to $110 from $100 at BMO Capital

BMO Capital analyst Keith Bachman raised his price target on Atlassian to $110, saying that while its Q3 result was not as "good as it looked", its guidance for Q4 was not as bad. The analyst cites the changes in pricing, which he says "meaningfully exacerbate seasonality of billings", also estimating the company's billings growth at an "impressive" 35%-40%. Bachman is keeping his Market Perform rating on Atlassian, noting that while the company offers a "compelling product suite" with "innovative pricing strategy", its current valuation does not offer a "favorable risk/reward."

  • 05

    Jun

TEAM Atlassian
$111.23

-2.02 (-1.78%)

04/12/19
ADAM
04/12/19
NO CHANGE
Target $125
ADAM
Buy
Atlassian price target raised to $125 at Canaccord after analyst day
Canaccord analyst Richard Davis said after attending Atlassian's analyst day meeting that he believes the stock should be a core holding "in just about any portfolio," stating that data points collected during the company's Summit event "augment, and disproportionately support our favorable view on this company's fundamental outlook." Despite worries about valuation, he sees a reasonable case that the stock could double in 4-5 years, said Davis, who raised his price target on Atlassian to $125 from $105 and keeps a Buy rating on the shares.
04/18/19
JEFF
04/18/19
NO CHANGE
Target $105
JEFF
Hold
Atlassian reported 'decent' Q3 results, says Jefferies
Atlassian reported "decent" fiscal Q3 results that reflected a greater pull forward of business to Q2 due to an imminent price increase than reflected in consensus billings expectations, Jefferies analyst John DiFucci tells investors in a research note. The analyst, while still viewing Atlassian as a "unique asset with very substantial opportunity," keeps a Hold rating on the shares with a $105 price target citing a "rich" valuation.
04/18/19
MZHO
04/18/19
NO CHANGE
Target $125
MZHO
Buy
Mizuho still comfortable buying Atlassian shares despite billings miss
Although Atlassian's fiscal Q3 revenue and earnings upside "was solid," billings were below consensus, Mizuho analyst Gregg Moskowitz tells investors in a post-earnings research note. However, his work indicates a "high likelihood" that this is solely a function of a greater than expected pull forward impact in fiscal Q2. Normalizing for this, the analyst estimates "very healthy" fiscal Q3 billings growth in the high 30% range. Moskowitz remains buying the shares, "especially on any significant weakness." He keeps a Buy rating on Atlassian with a $125 price target.
04/18/19
MSCO
04/18/19
NO CHANGE
Target $99
MSCO
Underweight
Atlassian billings slowdown should make investors reassess, says Morgan Stanley
Morgan Stanley analyst Keith Weiss said he believes that Atlassian "truly is a great company" and "it's hard to be Underweight great companies," but leading into the company's earnings report he thought expectations appeared too high and coming out of the report he thinks the company's sharp deceleration in Q3 billings growth "likely forces investors to reassess the durable growth rate at Atlassian." Billings growth fell sharply to 31% year-over-year in Q3, noted Weiss, who sees "low thirties" as a more durable growth rate for Atlassian. He'd look to get more constructive if multiples better align to the trajectories of Atlassian's durable growth and margin expansion, said the analyst, who maintains an Underweight rating on the stock and raised his price target to $99 from $97.

TODAY'S FREE FLY STORIES

VCYT

Veracyte

$28.50

-0.16 (-0.56%)

16:24
12/13/19
12/13
16:24
12/13/19
16:24
Conference/Events
Veracyte management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

MCK

McKesson

$140.56

-3.44 (-2.39%)

16:21
12/13/19
12/13
16:21
12/13/19
16:21
Conference/Events
McKessonto hold a sell-side analyst meeting »

Sell-Side Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MDR

McDermott

$0.82

0.0412 (5.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Hot Stocks
McDermott discloses NYSE delisting notice »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.26

-1.52 (-1.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 26

    Mar

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 13th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPWR

Ideal Power

$2.45

0.04 (1.66%)

16:19
12/13/19
12/13
16:19
12/13/19
16:19
Syndicate
Breaking Syndicate news story on Ideal Power »

Ideal Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIE

Erie Indemnity

$168.97

0.25 (0.15%)

16:18
12/13/19
12/13
16:18
12/13/19
16:18
Hot Stocks
Erie Indemnity increases quarterly dividend »

The board of Erie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ESRT

Empire State Realty

$13.68

0.055 (0.40%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Empire State Realty renews $500M stock repurchase program »

Empire State Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPS Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HST

Host Hotels

$17.95

0.09 (0.50%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Host Hotels declares special dividend of 5c per share »

Host Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
12/13/19
12/13
16:16
12/13/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACW

PacWest Bancorp

$38.11

-0.54 (-1.40%)

16:14
12/13/19
12/13
16:14
12/13/19
16:14
Hot Stocks
PacWest Bancorp CEO buys 6.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.03

-1.75 (-1.51%)

16:13
12/13/19
12/13
16:13
12/13/19
16:13
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

OC

Owens Corning

$64.62

-1.03 (-1.57%)

16:13
12/13/19
12/13
16:13
12/13/19
16:13
Hot Stocks
Owens Corning exec chairman Thaman sells 30,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRR

Carbo Ceramics

$0.42

0.0132 (3.21%)

16:11
12/13/19
12/13
16:11
12/13/19
16:11
Hot Stocks
Carbo Ceramics to delist from NYSE, applies to list on OTCQB market »

CARBO Ceramics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$0.79

-0.0009 (-0.11%)

16:07
12/13/19
12/13
16:07
12/13/19
16:07
Hot Stocks
Chesapeake receives continued listing notice from NYSE »

Chesapeake Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCVL

Shoe Carnival

$36.15

-1.43 (-3.81%)

16:06
12/13/19
12/13
16:06
12/13/19
16:06
Hot Stocks
Shoe Carnival announces new $50M share repurchase program »

Shoe Carnival announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$0.91

0.0192 (2.15%)

16:05
12/13/19
12/13
16:05
12/13/19
16:05
Hot Stocks
22nd Century CEO Cliff Fleet to step down »

22nd Century announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

16:03
12/13/19
12/13
16:03
12/13/19
16:03
Hot Stocks
Horizon Pharma: FDA committee votes unanimously to support use of teprotumumab »

Horizon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

MUX

McEwen Mining

$1.11

0.03 (2.79%)

16:03
12/13/19
12/13
16:03
12/13/19
16:03
Conference/Events
McEwen Mining to host conference call »

Chief Owenr McEwen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PJC

Piper Jaffray

$81.49

0.13 (0.16%)

16:00
12/13/19
12/13
16:00
12/13/19
16:00
Hot Stocks
Piper Jaffray announces ticker symbol change to PIPR »

Piper Jaffray Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$357.90

-1.8 (-0.50%)

15:56
12/13/19
12/13
15:56
12/13/19
15:56
Periodicals
NHTSA to probe December 7 crash of Tesla Model 3, Reuters reports »

The U.S. National Highway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Mar

TME

Tencent Music

$11.46

-0.54 (-4.50%)

15:55
12/13/19
12/13
15:55
12/13/19
15:55
Options
Tencent put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAYF

Hudson's Bay

$0.00

(0.00%)

15:46
12/13/19
12/13
15:46
12/13/19
15:46
Periodicals
Hudson's Bay take-private deal fails to secure investor support, Reuters says »

Hudson's Bay has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.